tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co (JP:4527)
:4527
Japanese Market

Rohto Pharmaceutical Co (4527) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

4527 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Rohto
Pharmaceutical Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4527 Stock 12 Month Forecast

There Are No Analyst Ratings for JP:4527 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

4527 Financial Forecast

4527 Earnings Forecast

Next quarter’s earnings estimate for 4527 is ¥28.79 with a range of ¥28.79 to ¥28.79. The previous quarter’s EPS was ¥26.03. 4527 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year 4527 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 4527 is ¥28.79 with a range of ¥28.79 to ¥28.79. The previous quarter’s EPS was ¥26.03. 4527 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year 4527 has Performed in-line its overall industry.

4527 Sales Forecast

Next quarter’s sales forecast for 4527 is ¥91.47B with a range of ¥88.80B to ¥96.10B. The previous quarter’s sales results were ¥82.29B. 4527 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year 4527 has Performed in-line its overall industry.
Next quarter’s sales forecast for 4527 is ¥91.47B with a range of ¥88.80B to ¥96.10B. The previous quarter’s sales results were ¥82.29B. 4527 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year 4527 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
¥2,100¥2,700
Hold
5.47%
Upside
Reiterated
09/04/25
Rohto Pharmaceutical Co Ltd (4527:JP) PT Raised to JPY2,700 at CitiCiti analyst Hiroki Watanabe raised the price target on Rohto Pharmaceutical Co Ltd (4527:JP) to JPY2,700.00 (from JPY2,100.00) while maintaining a Neutral rating.
J.P. Morgan Analyst forecast on JP:4527
J.P. Morgan
J.P. Morgan
¥2,700¥2,900
Buy
13.28%
Upside
Reiterated
08/27/25
J.P. Morgan Remains a Buy on Rohto Pharmaceutical Co (RPHCF)
Jefferies
¥1,750¥2,000
Sell
-21.88%
Downside
Reiterated
08/18/25
Rohto Pharmaceutical Co (RPHCF) Gets a Sell from Jefferies
Morgan Stanley Analyst forecast on JP:4527
Morgan Stanley
Morgan Stanley
¥3,900¥3,500
Buy
36.72%
Upside
Reiterated
06/30/25
Morgan Stanley Keeps Their Buy Rating on Rohto Pharmaceutical Co (RPHCF)
Nomura
¥3,240¥2,750
Buy
7.42%
Upside
Reiterated
05/29/25
Rohto Pharmaceutical Co (RPHCF) Gets a Buy from Nomura
Goldman Sachs Analyst forecast on JP:4527
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
¥3,100¥2,750
Buy
7.42%
Upside
Reiterated
05/14/25
Target Price Changes; PT lowered to ¥2750
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
¥2,100¥2,700
Hold
5.47%
Upside
Reiterated
09/04/25
Rohto Pharmaceutical Co Ltd (4527:JP) PT Raised to JPY2,700 at CitiCiti analyst Hiroki Watanabe raised the price target on Rohto Pharmaceutical Co Ltd (4527:JP) to JPY2,700.00 (from JPY2,100.00) while maintaining a Neutral rating.
J.P. Morgan Analyst forecast on JP:4527
J.P. Morgan
J.P. Morgan
¥2,700¥2,900
Buy
13.28%
Upside
Reiterated
08/27/25
J.P. Morgan Remains a Buy on Rohto Pharmaceutical Co (RPHCF)
Jefferies
¥1,750¥2,000
Sell
-21.88%
Downside
Reiterated
08/18/25
Rohto Pharmaceutical Co (RPHCF) Gets a Sell from Jefferies
Morgan Stanley Analyst forecast on JP:4527
Morgan Stanley
Morgan Stanley
¥3,900¥3,500
Buy
36.72%
Upside
Reiterated
06/30/25
Morgan Stanley Keeps Their Buy Rating on Rohto Pharmaceutical Co (RPHCF)
Nomura
¥3,240¥2,750
Buy
7.42%
Upside
Reiterated
05/29/25
Rohto Pharmaceutical Co (RPHCF) Gets a Buy from Nomura
Goldman Sachs Analyst forecast on JP:4527
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
¥3,100¥2,750
Buy
7.42%
Upside
Reiterated
05/14/25
Target Price Changes; PT lowered to ¥2750
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rohto Pharmaceutical Co

1 Month
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+3.52%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +3.52% per trade.
3 Months
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
+2.95%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +2.95% per trade.
1 Year
Akiko KuwaharaJ.P. Morgan
Success Rate
4/8 ratings generated profit
50%
Average Return
-2.43%
reiterated a buy rating 4 months ago
Copying Akiko Kuwahara's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -2.43% per trade.
2 Years
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
+0.30%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4527 Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
4
7
6
4
2
Buy
0
0
0
0
0
Hold
2
3
2
3
1
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
7
11
9
8
4
In the current month, 4527 has received 2 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. 4527 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

4527 Stock Forecast FAQ

What is JP:4527’s average 12-month price target, according to analysts?
Currently, no data Available
What is JP:4527’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:4527, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Rohto Pharmaceutical Co a Buy, Sell or Hold?
      Currently, no data Available
      What is Rohto Pharmaceutical Co’s share price target?
      Currently, no data Available
      What do analysts say about Rohto Pharmaceutical Co?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Rohto Pharmaceutical Co?
      To buy shares of JP:4527, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.